Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pseudo-resistant Bacillus cereus uses biofilm-related mechanism to mimic vancomycin resistance during agar diffusion susceptibility testing

ABSTRACT: Pseudo-resistant Bacillus cereus uses biofilm-related mechanism to mimic vancomycin resistance during agar diffusion susceptibility testing

PROVIDER: PRJNA1064106 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27533700_1.fastq.gz	Fastqsanger.gz
	SRR27533800_1.fastq.gz	Fastqsanger.gz
	SRR27533701_1.fastq.gz	Fastqsanger.gz
	SRR27533801_1.fastq.gz	Fastqsanger.gz
	SRR27533702_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 175

Similar Datasets

Pseudo-resistant Bacillus cereus uses biofilm-related mechanism to mimic vancomycin resistance during agar diffusion susceptibility testing

Project description:The glycopeptide vancomycin is a drug of choice for the treatment of severe non-gastrointestinal infections with members of Bacillus cereus sensu lato. Recently, sporadic detection of vancomycin resistant phenotypes emerged, mostly for agar diffusion testing. The food packaging isolate BC70 displayed a pseudo-resistant phenotype for vancomycin in both Etest and disk diffusion. In this work, we used RNA-Seq on the nanopore platform to study differentially expressed genes in BC70 cells, which were able to actively move into the inhibition zone during vancomycin susceptibility testing using Etest and therefore appeared to be resistant. Transcriptomic analysis revealed several key genes of biofilm formation (e.g. calY, tasA, krsEABC) to be upregulated in pseudo-resistant cells suggesting a biofilm-related mechanism of motility. Downregulation of virulence (e.g. hblABCD, nheABC, plcR) and flagellar genes compared to swarming cells also confirmed the non-swarming phenotype of the pseudo-resistant isolate. This type of biofilm-related motility was distinct from swarming motility and joined the list of bacterial strategies interfering with reliable antimicrobial susceptibility testing.

2024-07-10 | GSE253142 | GEO

Counter-diffusion DNBR

Project description:Counter-diffusion DNBR Raw sequence reads

| PRJNA1146795 | ENA

Pseudo-nitzschia

Project description:Pseudo-nitzschia sp. overview

| PRJNA1276220 | ENA

DNA-Diffusion STARR-Seq Validation

Project description:To test how DNA-Diffusion sequences can induce transcription, we select 2150 sequences, including DNA-Diffusion synthetic and natural occurring DHS sites for each cell type (K562, HepG2, and GM12878) and insert them into STARR-Seq plasmids (N= 6450 sequences). all synthetic and naturally occurring sequences were combined into a single library, and this same library was experimentally tested using STARR-Seq in different cell lines (K562, HepG2, GM12878).

2025-10-07 | GSE293971 | GEO

Pseudo-nitzschia multiseries

Project description:Pseudo-nitzschia multiseries overview

| PRJNA287468 | ENA

Pseudo-nitzschia multistriata

Project description:Pseudo-Nitzschia multistriata Project

| PRJNA80045 | ENA

Pseudo-nitzschia multistriata

Project description:Pseudo-nitzschia multistriata transcriptome

| PRJNA287788 | ENA

Pseudo-nitzschia multistriata

Project description:Pseudo-nitzschia multistriata overview

| PRJNA84105 | ENA

DNA-Diffusion STARR-Seq Validation

Project description:DNA-Diffusion STARR-Seq Validation

| PRJNA1247511 | ENA

In Vitro Validation of DNA-Diffusion and Control Sequences within the AXIN2 Locus [nanopore_plasmid]

Project description:DNA-Diffusion is a novel generative approach leveraging diffusion probabilistic models for the design of cell type-specific DNA regulatory sequences. To evaluate the capacity of DNA-Diffusion sequences to endogenously alter AXIN2 transcription, we employed a novel MPRA-like system that utilizes CRE-recombinase mediated cassette exchange and long-read sequencing to measure the gene’s transcriptional output in response to enhancer sequences several kilobases away. We evaluated a total of 100 sequences using the AXIN2 endogenous replacement experiment using the following sequence groups: GM12878 DNA-Diffusion, GM12878 Positive Controls, GM12878 Negative Controls, K562 DNA-Diffusion, HepG2 DNA-Diffusion, and shuffled GM12878 DNA-Diffusion. Our findings demonstrate the potential of DNA-Diffusion to design sequences with therapeutic potential, showing their effectiveness in an endogenous setting.

2025-07-13 | GSE269921 | GEO